Compare APC & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APC | KURA |
|---|---|---|
| Founded | 2025 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 819.0M | 744.0M |
| IPO Year | N/A | 2015 |
| Metric | APC | KURA |
|---|---|---|
| Price | $19.02 | $9.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $26.63 |
| AVG Volume (30 Days) | 182.2K | ★ 1.5M |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,482,000.00 |
| Revenue This Year | N/A | $124.03 |
| Revenue Next Year | N/A | $28.63 |
| P/E Ratio | $25.80 | ★ N/A |
| Revenue Growth | N/A | ★ 25.24 |
| 52 Week Low | $17.82 | $5.41 |
| 52 Week High | $19.80 | $12.49 |
| Indicator | APC | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 68.42 | 65.41 |
| Support Level | N/A | $8.95 |
| Resistance Level | $19.65 | $10.50 |
| Average True Range (ATR) | 0.63 | 0.39 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 57.58 | 99.35 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.